The scientific community and the world at large are still reeling from the news that a rogue Chinese scientist conducted experiments that ultimately resulted in CRISPR-edited twin girls. The scientist's behavior may have been anomalous, but the use of CRISPR and other gene-editing technologies is something we've been tracking here at Stratfor for a number of years. The potential applications spread across a wide swath of sectors, from agriculture to industry to medicine. Much as we see a tech race on artificial intelligence between China and the United States, we expect a similar one in biotech....